Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2002
06/13/2002WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders
06/13/2002WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
06/13/2002WO2002046443A2 Transcriptional regulator nucleic acids, polypeptides and methods of use thereof
06/13/2002WO2002046442A2 Phosphatase stress-related proteins and methods of use in plants
06/13/2002WO2002046441A2 Targets for herbicides and transgenic plants resistant to said herbicides
06/13/2002WO2002046439A2 A novel root specific promoter driving the expression of a novel lrr receptor-like kinase
06/13/2002WO2002046437A2 Methods and compositions for highly efficient production of heterologous proteins in yeast
06/13/2002WO2002046431A1 Model for hematopoietic cell growth, differentiation and disease
06/13/2002WO2002046430A2 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
06/13/2002WO2002046424A2 Fibroblast growth factors
06/13/2002WO2002046423A2 Protein derived from the melanin-concentrating hormone (mch), corresponding nucleic acids and their use for preparing medicines
06/13/2002WO2002046421A2 Methods and compositions for analysis of m3 muscarinic acetylchloine receptors
06/13/2002WO2002046420A2 Nebulin-related protein
06/13/2002WO2002046419A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
06/13/2002WO2002046418A2 Lipid-associated molecules
06/13/2002WO2002046417A2 Adipocyte complement related protein zacrp3x2
06/13/2002WO2002046416A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
06/13/2002WO2002046415A2 Polynucleotide and polypeptide sequences of putative transporters and ion channells
06/13/2002WO2002046414A2 Human g-protein coupled receptor expressed highly in kidney
06/13/2002WO2002046413A2 Molecules for disease detection and treatment
06/13/2002WO2002046412A2 Regulation of angiogenesis with zinc finger proteins
06/13/2002WO2002046411A2 Intestinal proteins
06/13/2002WO2002046410A2 Prostate-specific polypeptide pamp and encoding nucleic acid molecules
06/13/2002WO2002046409A2 Proteins and nucleic acids encoding same
06/13/2002WO2002046408A2 Human proteins, polynucleotides encoding them and methods of using the same
06/13/2002WO2002046407A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046406A2 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
06/13/2002WO2002046405A1 Process for producing rfrp
06/13/2002WO2002046404A2 Schizophrenia-related voltage-gated ion channel gene and protein
06/13/2002WO2002046403A2 Regulation of human patched-like protein
06/13/2002WO2002046402A2 Regulation of human patched-like protein
06/13/2002WO2002046401A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue
06/13/2002WO2002046400A2 Mutated class ii major histocompatibility proteins
06/13/2002WO2002046394A1 Novel g protein-coupled receptor protein and dna thereof
06/13/2002WO2002046392A2 X ray crystal structures at 5.5 a resolution of functional complexes of the bacterial ribosome containing transfer rna and model messenger rnas
06/13/2002WO2002046391A2 Transgenic mice containing nori gene disruptions
06/13/2002WO2002046389A2 Genes associated with allergic hypersensitivity and mast cell activation
06/13/2002WO2002046386A2 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
06/13/2002WO2002046383A2 Protein modification and maintenance molecules
06/13/2002WO2002046369A2 Yeast-based assays involving gpcrs
06/13/2002WO2002046364A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof
06/13/2002WO2002046362A2 Gene associated with benign prostatic hyperplasia in humans
06/13/2002WO2002046238A2 Rationally designed antibodies
06/13/2002WO2002046237A2 Humanized antibodies that recognize beta amyloid peptide
06/13/2002WO2002046231A2 Caml-binding peptides
06/13/2002WO2002046230A2 G-protein coupled receptors
06/13/2002WO2002046229A2 Novel proteins and nucleic acids encoding same
06/13/2002WO2002046228A2 Receptor for b. anthracis toxin
06/13/2002WO2002046227A2 Glp-1 fusion proteins
06/13/2002WO2002046226A2 Trefoil factor 2 (tff2) peptides with moiety attached to asn15
06/13/2002WO2002046225A2 Use of sarp-1 for the treatment and/or prevention of scleroderma
06/13/2002WO2002046224A2 Compositions and methods relating to lung specific genes and proteins
06/13/2002WO2002046223A2 Compositions and methods related to the minn1 tumor suppressor gene and protein
06/13/2002WO2002046222A2 Compositions and methods for diagnosing alzheimer's disease
06/13/2002WO2002046221A2 Human protein differentially expressed in alzheimer's disease's brain
06/13/2002WO2002046220A2 Sequences upstream of the carp gene, vectors containing them and uses thereof
06/13/2002WO2002046219A2 Rho-gtpase activating proteins and methods related thereto
06/13/2002WO2002046218A2 Treatment of disease by inducing cell apoptosis
06/13/2002WO2002046217A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046216A2 Human sprouty-4 polypeptide
06/13/2002WO2002046215A2 Basb221 polypeptides and polynucleotides encoding basb221 polypeptides
06/13/2002WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2002WO2002046212A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046211A2 Peptides derived from colostrinin
06/13/2002WO2002046210A1 Method for preparing tryptophan rich peptides
06/13/2002WO2002046208A2 Method of producing biospecific molecules by protein trans-splicing
06/13/2002WO2002045755A2 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma
06/13/2002WO2002045747A1 Immunotherapeutic combinations for the treatment of tumors
06/13/2002WO2002045744A1 Spliced gene of kshv/hhv8, its promoter and monoclonal antibodies specific for lana2
06/13/2002WO2002045743A2 Hcv vaccines
06/13/2002WO2002045739A1 Immunomodulatory constructs and their uses
06/13/2002WO2002045738A2 Vaccine composition containing transforming growth factor alpha
06/13/2002WO2002045736A1 Methods for improved diagnosis and treatment of mycobacterial infections
06/13/2002WO2002045708A2 Use of zwitterionic polysaccharides for the specific modulation of immune processes
06/13/2002WO2002045659A2 Novel therapeutics for heart failure and aging
06/13/2002WO2002045657A2 Ovarian tumor antigen and methods of use therefor
06/13/2002WO2002045522A1 Isolation method
06/13/2002WO2002045503A2 Transgenic mice containing targeted gene disruptions
06/13/2002WO2002045498A2 Transgenic mice containing channel protein target gene disruptions
06/13/2002WO2002045496A2 Transenic mice containing frp-rs4 gene disruptions
06/13/2002WO2002045495A2 Transgenic mice containing targeted gene disruptions
06/13/2002WO2002045494A2 Transgenic mice containing glucagon receptor gene disruptions
06/13/2002WO2002045492A2 Transgenic mice containing polycystin-related gene disruptions
06/13/2002WO2002045486A1 Method for modifying a plant phenotype
06/13/2002WO2002028419A3 Chemokine mutants in the treatment of multiple sclerosis
06/13/2002WO2002028348A3 Compositions and methods for treatment of cystic fibrosis
06/13/2002WO2002026929A3 Kini-3 motor protein and methods for its use
06/13/2002WO2002026770A3 Haplotypes of the admr gene
06/13/2002WO2002024915A8 Dcta (c4-dicarboxylate transporter) from corynebacterium glutamicum
06/13/2002WO2002022848A3 Compositions comprising mixtures of human cytokines and methods of producing the same
06/13/2002WO2002022663A3 Stress resistant retroviruses
06/13/2002WO2002020793A8 Chra of corynebacterium glutamicum
06/13/2002WO2002020554A3 Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines
06/13/2002WO2002016402A3 Apoptotic compounds
06/13/2002WO2002014532A3 Method for identifying modulators of 'mec'-induced functions of ccr3 and/or ccr10
06/13/2002WO2002014357A3 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage
06/13/2002WO2002012339A3 Sequences for integrin alpha-8
06/13/2002WO2002012278A3 Pseudo-metalloproteins, corresponding preparation and use as biosensors
06/13/2002WO2002008418A3 Method of isolation of regulated virulence determinants from bacterial pathogens
06/13/2002WO2002008263A3 Modified virus having an altered tropism
1 ... 1815 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 ... 2916